Background: Aortic dilatation and dissection are severe complications of pregnancy that may cause maternal death. The purpose of the present study was to investigate risk factors for aortic dilatation or dissection in pregnant Japanese women with Marfan syndrome.
arfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in the fibrillin-1 (FBN1) gene located on chromosome 15. 1 These mutations result in weakness of the supportive tissue of the body, and clinical characteristics include symptoms of the cardiovascular, skeletal, and ocular systems. 2, 3 Cardiovascular complications are the main cause of morbidity and mortality in patients with Marfan syndrome. 4 Before the development of preventive surgical approaches to aortic diseases, the mean life expectancy for a patient with Marfan syndrome was <40 years, with aortic dissection, aortic rupture and cardiac failure being the predominant causes of death. 5 Beta-blocker therapy and elective surgical repair, however, have increased life expectancy to near normal values. 6 
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Pregnancy is strongly associated with life-threatening problems in Marfan patients. The risk of aortic dilatation or dissection increases during and after pregnancy in patients with Marfan syndrome due to superimposition of the hyperdynamic and hypervolemic circulatory state of pregnancy on the preexisting weakness of the aortic media. 3 The rate of aortic dissection during pregnancy has been studied in previous reports. In 1981, Pyeritz reported no aortic complications during 105 pregnancies in 26 women affected by Marfan syndrome, based on phone interviews. 7 Rossiter et al prospectively followed 45 pregnancies in 21 women, and found 2 cases complicated by dissection; 8 Lipscomb et al reported 6 aortic events, including 4 aortic dissections, in 91 pregnancies in 36 women; 9 Lind and Wallenburg found 5 aortic dissections in 117 pregnancies; 10 and Pacini et al reported 7 aortic dissections in 160 pregnancies in 85 women. 11 Combining all these data gives a risk of 3.9% for aortic complication during pregnancy in women with Marfan syndrome who are not taking β-blockers.
The indicators of aortic risk in pregnancy are an aortic diam-
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eter ≥4.0 cm 7-10,12,13 and a steady increase in the aortic root dimension during pregnancy. 9,10, 14 Meijboom et al reported that pregnancy in women with Marfan syndrome seems to be relatively safe up to an aortic root diameter of 45 mm. 15 Most previous reports on Marfan syndrome in pregnancy, however, have been from North America or Europe, and people in these areas have relatively large physiques, and patient physique was not standardized. Because normal aortic dimensions vary with age and body size, 16 the same aortic dimension represents a proportionally greater diameter in smaller individuals, and proper interpretation of the aortic dimension requires that age and body size are accounted for. Therefore the absolute aortic size cannot be directly used to evaluate risk in patients with a small physique, 17 such as Japanese women. The risk factors for aortic complications in pregnant patients affected with Marfan syndrome have not been examined relative to body surface area. Therefore, to improve patient management, we studied 28 consecutive pregnant patients with Marfan syndrome in 1 institution to determine the factors that influence maternal aortic complications.
Methods

Patients
We retrospectively analyzed 28 consecutive pregnant patients with Marfan syndrome who were managed at the National Cerebral and Cardiovascular Center from 1991 to 2007. Diagnosis of Marfan syndrome was made based on the original Ghent criteria (1996) . 18 Cases before 1996 were confirmed to fulfill these criteria. The initial assessment included an evaluation of personal history and detailed family history, and a clinical examination including ophthalmological tests and a transthoracic echocardiogram. 3 X-ray was used to detect protrusion acetabulae, and lumbar magnetic resonance imaging (MRI) was performed to detect dural ectasia.
We divided the patients into 2 groups: those with aortic dilatation or dissection (group D, n=11) during pregnancy or within 1 year after delivery and those without aortic dilatation or dissection (group ND, n=17). Aortic dilatation was defined as a diameter >60 mm at any part of the aorta.
Measurement of Aortic Diameter and Indication for Surgery
Measurement of the sinus of Valsalva was made on echocardiography in 2-D parasternal long-axis views at end-diastole using the leading edge to leading edge method. 16, 19 MRI and computed tomography were not routinely used. The Japanese Circulation Society recommends an operation for patients with a sinus of Valsalva >5 cm (class IIa, level C) in all cases of Marfan syndrome. 20 Some surgeons also recommend an operation for patients with a sinus of Valsalva >4.5 cm. 21 At the National Cerebral and Cardiovascular Center, surgical intervention is indicated according to the aforementioned criteria and for patients with a family history of dissection or sudden death. In general, surgical intervention is indicated for a sinus of Valsalva >4.0 cm or in a case of steady aortic growth. 22, 23 During pregnancy, surgical intervention is indicated if there is steady aortic growth or massive dissection. To standardize the measurement based on body size, we expressed the size of the sinus of Valsalva using the aortic size index (ASI), which is calculated as: ASI = aortic diameter (mm) / body surface area (m 2 ). 17
Management During Pregnancy
Echocardiographic follow-up including aortic diameter measurement and Holter electrocardiogram was performed at least once in each trimester during pregnancy and within 4 weeks after delivery. When surgical intervention was indicated, the operation was performed after cesarean section in the case of a mature fetus. When the fetus was too immature to live independently, the operation was performed with the fetus in the uterus. Table 1 .
Pregnancy-Associated Aortic Dissection in Marfan Syndrome
Data Collection
Data were collected on family history (sudden death, aortic dilatation or dissection), maternal age, body height, body weight, parity, presence or absence of hypertension, diabetes mellitus, change in the diameter of the sinus of Valsalva during and after pregnancy, right and left ventricular function, aortic valve regurgitation, mitral valve prolapse, delivery mode (Cesarean section or vaginal delivery), time of delivery (gestational weeks), and birth weight.
Statistical Analysis
For continuous variables, Student's t-test was used for analysis of normally distributed data and the Wilcoxon test was used for data that were not normally distributed. A chi-squared test and a Fisher's exact test were used for comparing categorical variables between the 2 groups. All statistical analyses were performed using JMP 7 (SAS Institute, Cary, NC, USA). P<0.05 was considered statistically significant.
Results
Aortic Dilatation or Dissection Group
Eleven patients had aortic dilatation or dissection associated with pregnancy (in 7 this occurred during pregnancy and in 4 it occurred within 1 year after pregnancy). 
Demographic Patient Data
The maternal age, week of delivery, and birth weight did not differ between the D and ND groups ( Table 1 ). The incidence of cesarean section was higher in group D than in group ND (7/11, 63.6% vs. 3/17, 17.6%, P<0.05). This was attributed to performance of cesarean section due to occurrence of dilatation or dissection of the aorta during pregnancy. The number of patients meeting each diagnostic category for Marfan syndrome (Ghent criteria, 1996) 18 is given in Table 2 . In group D, fewer patients met the major ocular criteria (2/10, 20% vs. Figure 1 ; Table 3 ) and a sinus of Valsalva ≥40 mm in the 1 st trimester was more frequent in group D (6/7, 86% vs. 3/14, 21%, P<0.05; Figure 1 ). On receiver operating characteristic (ROC) analysis of the relationship of the size of the sinus of Valsalva in the 1 st trimester with aortic dilatation or dissection during pregnancy and after birth, the area under the curve (AUC) was 0.837 and the size of the sinus of the Valsalva that produced the best sensitivity (1-specificity) was 40 mm (Figure 2 ). An ASI (diameter of the sinus of Valsalva/body surface area) ≥25 mm/m 2 was more frequent in group D than in group ND (7/7, 100% vs. 0/14, 0%; P<0.0001; Figure 3) . On ROC analysis of the relationship of the ASI in the 1 st trimester with aortic dilatation or dissection during pregnancy and after birth, the AUC was 0.985 and the size of the sinus of Valsalva that produced the best sensitivity (1-specificity) was 25 mm/m 2 . In 1 case, aortic dissection occurred in a patient with a sinus of Valsalva of only 36 mm in the 1 st trimester. Her ASI, however, was 27.3 mm/m 2 (36 mm/1.31 m 2 ), which was the 5 th largest in the study. This indicates that normalizing the sinus of Valsalva measurement with respect to body surface area is more appropriate for prediction of aortic dilatation or dissection, compared to the absolute diameter. 
Discussion
This is the first study to investigate the risk factors for pregnancy-associated dilatation or dissection in Japanese patients with Marfan syndrome. The risk factors that differed significantly between groups D and ND were mostly consistent with those found in previous studies. 7-10, 14 These factors included a large sinus of Valsalva, rapid growth of the sinus of Valsalva during pregnancy, moderate to severe aortic valve or mitral valve regurgitation, and a family history of sudden death or aortic dissection. We found that a large sinus of Valsalva (≥40 mm) at the start of pregnancy was a risk factor for dilatation or dissection during pregnancy and after birth. The present result differs from the findings of the relatively large prospective study by Meijboom et al, in which it was concluded that pregnancy in women with Marfan syndrome seems to be relatively safe up to an aortic root diameter of 45 mm, 15 and from Canadian guidelines that recommend that women with an aortic root diameter beyond 44 mm should be strongly discouraged from becoming pregnant. 24 Taking into account that Japanese women have a generally smaller physique than European and North American women, we recommend that the cut-off for Japanese patients for advice regarding avoidance of pregnancy should be a sinus of Valsalva diameter ≥40 mm, rather than ≥45 mm. In a case report on a patient who developed a massive retrograde type B aortic dissection 7 days after normal spontaneous vaginal delivery, Gandhi et al described the patient as "petite" (body surface area, 1.69 m 2 ), but this is still larger than the average Japanese woman. 25 We also suggest that normalizing the diameter of the sinus of Valsalva with regard to body surface area (diameter of the Valsalva/body surface area; mm/m 2 ) may be more appropriate for detection of high-risk cases at the start of pregnancy. The relative aortic size was first used to predict complications in patients with thoracic aortic aneurysms. 17 We found that an ASI ≥25 mm/m 2 in the 1 st trimester is associated with a high risk for aortic dilatation or dissection during pregnancy and after birth. The ASI is a novel measurement of relative aortic size that predicts rupture of aortic aneurysm, 17 and Davies et al found that the ASI was more important than absolute aortic size in predicting aortic complications, especially in smaller women such as those in the Japanese population. 17 We found that there was more rapid growth of the sinus of Valsalva in patients with Marfan syndrome with pregnancy-associated aortic dilatation or dissection, compared to those without these conditions. Therefore, even if the diameter of the sinus of the Valsalva is small, rapid growth carries a risk of aortic dissection or dilatation. The same phenomenon has been reported in non-pregnant cases of Marfan syndrome. Meijboom et al followed 108 women with Marfan syndrome and aortic root growth prospectively using serial echocardiograms, and found that the patients could be divided into 2 normally distributed groups based on aortic growth rates: 90% had slow growths and 10% had fast growth. 15 Significantly more dissections of the ascending aorta (25% vs. 4%, P<0.001) were observed in the fast growth group, and the average growth of the sinus of Valsalva in the fast group was 1.8 mm/year. The median growth in the present 5 cases of aortic dissection was as high as 4.1 mm/year. This large increase relative to that in the Meijboom et al study 15 is probably due to the maternal cardiovascular changes in pregnancy, including increased blood volume, heart rate, and stroke volume. 25 Furthermore, hormonally mediated histological changes also occur in the aorta, including a decrease in mucopolysaccharides and loss of elastic fibers in the aortic wall. 26-28 Care is therefore required in treating patients with a high growth rate of the sinus of Valsalva. The frequency and degree of aortic and mitral valve regurgitation were also higher in patients with aortic dilatation or dissection, and these valvular changes may have been the causes of dilatation or dissection. An international expert panel established the revised Ghent criteria in 2010, which, first, focused more on cardiovascular manifestations, and in which aortic dilatation/dissection and ectopia lentis are the cardinal clinical features. 29 Second, in these revised criteria, a more prominent role is assigned to molecular genetic testing of FBN1 and other relevant genes in the diagnostic assessment. Third, some of the less specific manifestations of Marfan syndrome were either removed or made less influential in the diagnostic evaluation of patients. The new criteria also differentiate Marfan syndrome from Marfan-related syndromes such as Loeys-Dietz syndrome, Ehlers-Danlos syndrome, and familial thoracic aortic aneurysm syndrome, which are associated with a significantly greater risk of cardiovascular problems. 29-31 In the present study, patients with dilatation or dissection of the aorta were less likely to meet major ocular criteria, and more likely to meet the major cardiovascular criteria and had a more frequent family history of dilatation or dissection. These findings indicate that the new diagnostic criteria for Marfan syndrome facilitate identification of high-risk patients for pregnancyassociated dilatation or dissection more accurately.
Study Limitations
The disease severity of the present patients may have been higher than that of general Marfan syndrome patients because the National Cerebral and Cardiovascular Center is a referral center for cardiovascular diseases, and we also perform gene analysis. 32 Therefore, most Marfan syndrome patients are referred to our center due to cardiovascular complications and many have a family history of aortic complications. Also, because we investigated the clinical courses of Marfan syndrome patients associated with pregnancy in one institution, only 28 patients were included in the study. The small number of subjects prevented correction of the results for the effects of potential confounding factors such as hypertension, and we could not perform multifactorial analysis. The present study, however, has the advantage of clear definition of medical and surgical treatment and obstetric management. Measurements of the aorta, ventricle and atrium, and the degree of mitral and aortic valve regurgitation were also better defined in the present study compared with multi-center studies. In future research we plan to investigate a larger cohort of patients to clarify the risk factors for dilatation or dissection of the aorta in patients with Marfan syndrome during pregnancy.
Conclusion
An increased size of the sinus of Valsalva (≥40 mm) was found in Japanese patients with Marfan syndrome who experienced aortic dilatation or dissection during or after pregnancy. The ASI (size of the sinus of Valsalva/body surface area) is a better indicator of the risk for aortic dilatation or dissection during pregnancy and after birth, compared to the absolute size of the sinus of Valsalva. Until a molecular-based approach is available to identify patients at high cardiovascular risk, echocardiographic variables will remain as the most important prognostic factors. Prospective validation of the present proposed criteria is needed, but we suggest that the present strategy may be particularly useful for treatment of women with a small physique, who are common in the Japanese population.
